EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimizing Early Ophthalmology Clinical Trials: Home OCT and Modeling Can Reduce Sample Size by 20% to 40%

Jacques Hermes, Bernhard Steiert

Translational Vision Science & Technology · 2025

DOI: 10.1167/tvst.14.9.2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Vision Science & Technology, 2025. Verfasst von Jacques Hermes und 1 weiteren Autor:innen. Beteiligte Einrichtung: Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland. Hauptthemen laut MEDLINE: Tomography, Optical Coherence, Clinical Trials as Topic, Ophthalmology, Retinal Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tomography, Optical CoherenceClinical Trials as TopicOphthalmologyRetinal DiseasesHumansSample SizeMonte Carlo MethodMaleFemale

Autor:innen und Institutionen

  • Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Institute of Physics, University of Freiburg, Freiburg, Germany.
  • Freiburg Center for Data Analysis and Modelling (FDM), University of Freiburg, Freiburg, Germany.

Zitieren

APA

Hermes, J., & Steiert, B. (2025). Optimizing Early Ophthalmology Clinical Trials: Home OCT and Modeling Can Reduce Sample Size by 20% to 40%. Translational Vision Science & Technology. https://doi.org/10.1167/tvst.14.9.2

Vancouver

Hermes J, Steiert B. Optimizing Early Ophthalmology Clinical Trials: Home OCT and Modeling Can Reduce Sample Size by 20% to 40%. Translational Vision Science & Technology. 2025. doi:10.1167/tvst.14.9.2

BibTeX
@article{Hermes2025,
  author = {Hermes, Jacques and Steiert, Bernhard},
  title = {Optimizing Early Ophthalmology Clinical Trials: Home OCT and Modeling Can Reduce Sample Size by 20% to 40%},
  journal = {Translational Vision Science & Technology},
  year = {2025},
  doi = {10.1167/tvst.14.9.2}
}
Kostenlos starten →